Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,845.20
(
-0.42%
)
Dow Jones
49,447.43
(
1.88%
)
Brent Oil
91.40
(
-1.36%
)
Bitcoin
75,314.72
(
1.97%
)
News Focus
News Focus
Post# of 821994
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

supersteve13

Send PM Follow Ignore
Followers 13
Posts 1246
Boards Moderated 0
Alias Born 09/28/2022

supersteve13

Re: skitahoe post# 643211

Thursday, 10/26/2023 2:16:30 PM

Thursday, October 26, 2023 2:16:30 PM

Post# of 821994
Optune was approved with zero OS benefit, despite OS being the primary endpoint. (EF11 trial). That trial failed by definition, whereas the Dcvax phase 3 met both of the prespecified primary endpoints in the SAP. :)

Keep these facts in mind when Ex repeats his lies. :)
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News